Also called: Thymalfasin, Zadaxin, Thymosin Alpha-1 LL-37 Nasal Stack
Thymosin Alpha-1 is a small protein made naturally in the body. It comes from a larger part of the body called the thymus. This part of the body is very important for the immune system. Scientists study this peptide to see how it helps the body fight off sickness. It is often looked at by researchers who want to learn more about immune health.
This peptide works by acting like a switch for the immune system. It helps the body find and fight germs better. When the body is weak, this peptide might help make it stronger. It tells the immune cells to wake up and do their job. This is why many people are interested in how it helps the body stay healthy.
While it shows promise, it is not a magic cure. Research is still being done to see exactly how well it works in humans. Some studies look good, but we need more proof. It is mostly used in labs right now. People should be careful and know that it is not yet a standard medicine for everyone.
Thymosin Alpha-1 (thymalfasin) is an approved medicine in more than 35 countries — as Zadaxin, for chronic hepatitis B and C and as an immune adjuvant — but it has never been approved by the US FDA. It is not on the FDA's Section 503A Bulks List, remains an unapproved new drug under the FD&C Act, and cannot lawfully be compounded by traditional 503A pharmacies in the US.
Benefits
The main themes across 153 research studies, in plain language.
Research suggests this peptide helps train and coordinate immune cells, potentially restoring balance in conditions like immunodeficiency, autoimmune disorders, and sepsis.
Clinical trials suggest it may act as an adjuvant to improve the effectiveness of vaccines, particularly in elderly populations or those with weak immune responses.
Studies indicate it may enhance the body's ability to fight viral infections, showing potential as an adjunct therapy for Hepatitis B/C, HIV, and COVID-19.
Laboratory research suggests it possesses direct or indirect antimicrobial properties, potentially enhancing the immune response against bacteria and fungi.
Animal studies imply it supports heart health by protecting cardiac tissue after injury, promoting blood vessel formation, and improving heart function post-heart attack.
Research highlights its role in stimulating the formation of new blood vessels, which is critical for healing wounds and repairing damaged tissues.
Evidence suggests it promotes the healing of skin, corneas, and internal organs by stimulating cell migration, angiogenesis, and the repair of damaged tissues.
Studies suggest it aids in the repair of muscle, tendons, and ligaments by activating satellite cells and promoting the structural regeneration of connective tissues.
Evidence points to a potential role in maintaining the gut lining, reducing intestinal inflammation, and correcting specific functional defects in digestive disorders.
Studies indicate it helps regulate inflammation by suppressing specific cytokines and signaling pathways, potentially benefiting conditions like arthritis, sepsis, and autoimmune dysregulation.
Findings show it may decrease cellular oxidative damage by amplifying the activity of natural antioxidant enzymes like catalase and glutathione peroxidase.
Research indicates it supports cell survival under stress by regulating autophagy, inhibiting cell death pathways, and maintaining genomic stability.
Research suggests it may help prevent excessive scar tissue formation in organs like the heart, liver, and lungs by modulating specific fibrotic signaling pathways.
Early animal studies suggest it might help regulate blood sugar levels and protect pancreatic function, though human data is limited.
Preliminary research suggests it may protect nerve cells, reduce neuroinflammation, and support recovery in models of traumatic brain injury, stroke, and neurodegenerative conditions.
Research indicates it may improve skin health by reducing wrinkles, increasing elasticity, and potentially stimulating hair follicle growth.
Research points to potential benefits in cancer care, where it may boost immune surveillance, enhance the effectiveness of chemotherapy, and improve survival rates in specific malignancies.
You just read the research on Thymosin Alpha-1. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.
No spam. Unsubscribe anytime.
1 reported routine — each line links to the source it came from.
From published sources
Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.
SubQ
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Safety
Adverse effects reported in the research and by community use.
Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Thymosin alpha-1 (thymalfasin) is a 28-amino-acid thymic peptide immunomodulator that enhances T-cell maturation/function and dendritic-cell activity, and modulates cytokines. It is approved (as Zadaxin) in 35+ countries as an immune adjuvant for chronic hepatitis B; in the US it holds FDA orphan-drug designation only and is not FDA-approved.
Evidence
Every claim above traces back to a source you can check — here are 113 of them.
Thymosin alpha 1: A comprehensive review of the literature
FDA orphan drug designation - Thymosin Alpha-1 (Ta1)
PubChem - Compound - Thymalfasin
Thymosin alpha1: a historical overview.
Thymosin alpha 1: A comprehensive review of the literature.
Thymosin activity in patients with cellular immunodeficiency.
Thymosin alpha 1: from bench to bedside.
From lab to bedside: emerging clinical applications of thymosin alpha 1.
Therapeutic applications of thymosin peptides: a patent landscape 2018-present.
Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials
Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials.
Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis
Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis.
Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.
Timeline
Key moments in Thymosin Alpha-1’s research and regulatory timeline — sourced and dated.
News
Dated, sourced reporting that mentions Thymosin Alpha-1.
Wondering how Thymosin Alpha-1 pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →Explore by goal
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.